2009Zhongguo tangniaobing zazhiRequires access

The relationship of adiponectin, leptin and adiponectin-leptin ratio with components of metabolic syndrome in patients with type 2 diabetes

Zhao Bao-zhe

Open publisher page 0 citations

Abstract

Objective To evaluate the associations of adiponectin, leptin, and their ratio (adiponectin/ leptin) with components of metabolic syndrome in patients with type 2 diabetes. Methods Two hundreds and sixty patients with newly diagnosed type 2 diabetes were investigated. The relationships of adiponectin, leptin and adiponectin/leptin(A/L) ratio with components of metabolic syndrome were studied. Results The odds ratio of A/L ratio affecting the occurrence of metabolic syndrome was 0.368 (95% CI, 0.171~0.791, P0.057). Overweight/obese patients had significantly lower levels of adiponectin and A/L ratio and higher leptin as compared with nonobese subjects. Insulin-sensitive patients had significantly higher levels of adiponectin and A/L ratio and lower leptin than those with IR after adjusting body mass index(BMI) and waist circumference. Conclusions For type 2 diabetes patients, adiponectin, leptin, A/L ratio are associated with obesity, insulin resistance, and the components of the metabolic syndrome.

About this research paper

What this paper is about

Objective To evaluate the associations of adiponectin, leptin, and their ratio (adiponectin/ leptin) with components of metabolic syndrome in patients with type 2 diabetes. Methods Two hundreds and sixty patients with newly diagnosed type 2 diabetes were investigated. The relationships of adiponectin, leptin and adiponectin/leptin(A/L) ratio with components of metabolic syndrome were studied. Results The odds ratio of A/L ratio affecting the occurrence of metabolic syndrome was 0.368 (95% CI, 0.171~0.791, P0.057). Overweight/obese patients had significantly lower levels of adiponectin and A/L ratio and higher leptin as compared with nonobese subjects. Insulin-sensitive patients had significantly higher levels of adiponectin and A/L ratio and lower leptin than those with IR after adjusting body mass index(BMI) and waist circumference. Conclusions For type 2 diabetes patients, adiponectin, leptin, A/L ratio are associated with obesity, insulin resistance, and the components of the metabolic syndrome.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the associations of adiponectin, leptin, and their ratio (adiponectin/ leptin) with components of metabolic syndrome in patients with type 2 diabetes. Methods Two hundreds and sixty patients with newly diagnosed type 2 diabetes were investigated. The relationships of adiponectin, leptin and adiponectin/leptin(A/L) ratio with components of metabolic syndrome were studied. Results The odds ratio of A/L ratio affecting the occurrence of metabolic syndrome was 0.368 (95% CI, 0.171~0.791, P0.057). Overweight/obese patients had significantly lower levels of adiponectin and A/L ratio and higher leptin as compared with nonobese subjects. Insulin-sensitive patients had significantly higher levels of adiponectin and A/L ratio and lower leptin than those with IR after adjusting body mass index(BMI) and waist circumference. Conclusions For type 2 diabetes patients, adiponectin, leptin, A/L ratio are associated with obesity, insulin resistance, and the components of the metabolic syndrome.

Key concepts: Adiponectin, Leptin, Internal medicine, Endocrinology, Metabolic syndrome, Medicine, Type 2 diabetes, Obesity

Related papers

Back to paper searchBrowse research topicsOriginal source
The relationship of adiponectin, leptin and adiponectin-leptin ratio with components of metabolic syndrome in patients with type 2 diabetes — Research Paper | ScholarLens